807 related articles for article (PubMed ID: 22673743)
61. B lymphocyte cytokines and rheumatic autoimmune disease.
Youinou P; Taher TE; Pers JO; Mageed RA; Renaudineau Y
Arthritis Rheum; 2009 Jul; 60(7):1873-80. PubMed ID: 19565509
[No Abstract] [Full Text] [Related]
62. Postprandial lipoproteins and the molecular regulation of vascular homeostasis.
Botham KM; Wheeler-Jones CP
Prog Lipid Res; 2013 Oct; 52(4):446-64. PubMed ID: 23774609
[TBL] [Abstract][Full Text] [Related]
63. Bromocriptine in rheumatic and autoimmune diseases.
McMurray RW
Semin Arthritis Rheum; 2001 Aug; 31(1):21-32. PubMed ID: 11503136
[TBL] [Abstract][Full Text] [Related]
64. The development of inflammatory arthritis and other rheumatic diseases following stem cell transplantation.
Barnabe CC; LeClercq SA; Fitzgerald AA
Semin Arthritis Rheum; 2009 Aug; 39(1):55-60. PubMed ID: 18519150
[TBL] [Abstract][Full Text] [Related]
65. Smoking and cardiovascular disease: mechanisms of endothelial dysfunction and early atherogenesis.
Messner B; Bernhard D
Arterioscler Thromb Vasc Biol; 2014 Mar; 34(3):509-15. PubMed ID: 24554606
[TBL] [Abstract][Full Text] [Related]
66. The inhibitory effects of transforming growth factor-beta-1 (TGF-beta1) in autoimmune diseases.
Prud'homme GJ; Piccirillo CA
J Autoimmun; 2000 Feb; 14(1):23-42. PubMed ID: 10648114
[TBL] [Abstract][Full Text] [Related]
67. The autoimmune origin of atherosclerosis.
Blasi C
Atherosclerosis; 2008 Nov; 201(1):17-32. PubMed ID: 18585722
[TBL] [Abstract][Full Text] [Related]
68. Innate lymphoid cells in autoimmunity: emerging regulators in rheumatic diseases.
Shikhagaie MM; Germar K; Bal SM; Ros XR; Spits H
Nat Rev Rheumatol; 2017 Mar; 13(3):164-173. PubMed ID: 28148916
[TBL] [Abstract][Full Text] [Related]
69. Neutrophils in the Pathogenesis of Rheumatic Diseases: Fueling the Fire.
Liu Y; Kaplan MJ
Clin Rev Allergy Immunol; 2021 Feb; 60(1):1-16. PubMed ID: 33155144
[TBL] [Abstract][Full Text] [Related]
70. Neuroimmunoendocrinology of the rheumatic diseases: past, present, and future.
Wilder RL
Ann N Y Acad Sci; 2002 Jun; 966():13-9. PubMed ID: 12114254
[TBL] [Abstract][Full Text] [Related]
71. Antigen-specific immunotherapies in rheumatic diseases.
Pozsgay J; Szekanecz Z; Sármay G
Nat Rev Rheumatol; 2017 Sep; 13(9):525-537. PubMed ID: 28701761
[TBL] [Abstract][Full Text] [Related]
72. Immune-regulatory mechanisms in systemic autoimmune and rheumatic diseases.
Nakken B; Alex P; Munthe L; Szekanecz Z; Szodoray P
Clin Dev Immunol; 2012; 2012():957151. PubMed ID: 22474487
[No Abstract] [Full Text] [Related]
73. Sensors of the innate immune system: their link to rheumatic diseases.
Theofilopoulos AN; Gonzalez-Quintial R; Lawson BR; Koh YT; Stern ME; Kono DH; Beutler B; Baccala R
Nat Rev Rheumatol; 2010 Mar; 6(3):146-56. PubMed ID: 20142813
[TBL] [Abstract][Full Text] [Related]
74. Anti-inflammatory and immunomodulating properties of statins. An additional tool for the therapeutic approach of systemic autoimmune diseases?
Meroni PL; Luzzana C; Ventura D
Clin Rev Allergy Immunol; 2002 Dec; 23(3):263-77. PubMed ID: 12402412
[TBL] [Abstract][Full Text] [Related]
75. Oxidized haemoglobin-driven endothelial dysfunction and immune cell activation: novel therapeutic targets for atherosclerosis.
Buttari B; Profumo E; Businaro R; Saso L; Capoano R; Salvati B; Riganò R
Curr Med Chem; 2013; 20(37):4806-14. PubMed ID: 23834168
[TBL] [Abstract][Full Text] [Related]
76. Oxidative Stress and Lipid Mediators Modulate Immune Cell Functions in Autoimmune Diseases.
Wójcik P; Gęgotek A; Žarković N; Skrzydlewska E
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33450863
[TBL] [Abstract][Full Text] [Related]
77. Myeloid Populations in Systemic Autoimmune Diseases.
Morell M; Varela N; Marañón C
Clin Rev Allergy Immunol; 2017 Oct; 53(2):198-218. PubMed ID: 28528521
[TBL] [Abstract][Full Text] [Related]
78. Interferon lambda in inflammation and autoimmune rheumatic diseases.
Goel RR; Kotenko SV; Kaplan MJ
Nat Rev Rheumatol; 2021 Jun; 17(6):349-362. PubMed ID: 33907323
[TBL] [Abstract][Full Text] [Related]
79. Role of the eNOS Uncoupling and the Nitric Oxide Metabolic Pathway in the Pathogenesis of Autoimmune Rheumatic Diseases.
Łuczak A; Madej M; Kasprzyk A; Doroszko A
Oxid Med Cell Longev; 2020; 2020():1417981. PubMed ID: 32351667
[TBL] [Abstract][Full Text] [Related]
80. The rationale for comparative studies of accelerated atherosclerosis in rheumatic diseases.
Gasparyan AY; Stavropoulos-Kalinoglou A; Mikhailidis DP; Toms TE; Douglas KM; Kitas GD
Curr Vasc Pharmacol; 2010 Jul; 8(4):437-49. PubMed ID: 19758114
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
